Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Chimeric yellow fever 17D-Zika virus (ChimeriVax-Zika) as a live-attenuated Zika virus vaccine.

Giel-Moloney M, Goncalvez AP, Catalan J, Lecouturier V, Girerd-Chambaz Y, Diaz F, Maldonado-Arocho F, Gomila RC, Bernard MC, Oomen R, Delagrave S, Burdin N, Kleanthous H, Jackson N, Heinrichs J, Pugachev KV.

Sci Rep. 2018 Sep 4;8(1):13206. doi: 10.1038/s41598-018-31375-9.

2.

Application of replication-defective West Nile virus vector to non-flavivirus vaccine targets.

Giel-Moloney M, Vaine M, Zhang L, Parrington M, Gajewska B, Vogel TU, Pougatcheva SO, Duan X, Farrell T, Ustyugova I, Phogat S, Kleanthous H, Pugachev KV.

Hum Vaccin Immunother. 2017 Dec 2;13(12):2982-2986. doi: 10.1080/21645515.2017.1373920. Epub 2017 Sep 19.

3.

A novel approach to a rabies vaccine based on a recombinant single-cycle flavivirus vector.

Giel-Moloney M, Rumyantsev AA, David F, Figueiredo M, Feilmeier B, Mebatsion T, Parrington M, Kleanthous H, Pugachev KV.

Vaccine. 2017 Dec 14;35(49 Pt B):6898-6904. doi: 10.1016/j.vaccine.2017.08.055. Epub 2017 Sep 9.

PMID:
28899628
4.

Preparation of pure, high titer, pseudoinfectious Flavivirus particles by hollow fiber tangential flow filtration and anion exchange chromatography.

Mundle ST, Giel-Moloney M, Kleanthous H, Pugachev KV, Anderson SF.

Vaccine. 2015 Aug 20;33(35):4255-60. doi: 10.1016/j.vaccine.2014.09.074. Epub 2014 Dec 9.

PMID:
25498209
5.

Preclinical and clinical development of a YFV 17 D-based chimeric vaccine against West Nile virus.

Dayan GH, Pugachev K, Bevilacqua J, Lang J, Monath TP.

Viruses. 2013 Dec 9;5(12):3048-70. doi: 10.3390/v5123048. Review.

6.

Single-dose vaccine against tick-borne encephalitis.

Rumyantsev AA, Goncalvez AP, Giel-Moloney M, Catalan J, Liu Y, Gao QS, Almond J, Kleanthous H, Pugachev KV.

Proc Natl Acad Sci U S A. 2013 Aug 6;110(32):13103-8. doi: 10.1073/pnas.1306245110. Epub 2013 Jul 15.

7.

Characterization of the RepliVax platform for replication-defective flavivirus vaccines.

Rumyantsev AA, Giel-Moloney M, Liu Y, Gao QS, Zhang ZX, Catalan J, Frolov I, Almond J, Kleanthous H, Pugachev KV.

Vaccine. 2011 Jul 18;29(32):5184-94. doi: 10.1016/j.vaccine.2011.05.032. Epub 2011 May 26.

PMID:
21620917
8.

Direct random insertion of an influenza virus immunologic determinant into the NS1 glycoprotein of a vaccine flavivirus.

Rumyantsev AA, Zhang ZX, Gao QS, Moretti N, Brown N, Kleanthous H, Delagrave S, Guirakhoo F, Collett MS, Pugachev KV.

Virology. 2010 Jan 20;396(2):329-38. doi: 10.1016/j.virol.2009.10.033. Epub 2009 Nov 12.

9.

Dynamics of infraslow potentials in the primary auditory cortex: component analysis and contribution of specific thalamic-cortical and non-specific brainstem-cortical influences.

Filippov IV, Williams WC, Krebs AA, Pugachev KS.

Brain Res. 2008 Jul 11;1219:66-77. doi: 10.1016/j.brainres.2008.04.011. Epub 2008 Apr 16.

PMID:
18534565
10.

Construction and biological characterization of artificial recombinants between a wild type flavivirus (Kunjin) and a live chimeric flavivirus vaccine (ChimeriVax-JE).

Pugachev KV, Schwaiger J, Brown N, Zhang ZX, Catalan J, Mitchell FS, Ocran SW, Rumyantsev AA, Khromykh AA, Monath TP, Guirakhoo F.

Vaccine. 2007 Sep 17;25(37-38):6661-71. Epub 2007 Jul 27.

PMID:
17693000
11.

A single M protein mutation affects the acid inactivation threshold and growth kinetics of a chimeric flavivirus.

Maier CC, Delagrave S, Zhang ZX, Brown N, Monath TP, Pugachev KV, Guirakhoo F.

Virology. 2007 Jun 5;362(2):468-74. Epub 2007 Feb 15.

12.

Sound-induced changes of infraslow brain potential fluctuations in the medial geniculate nucleus and primary auditory cortex in anaesthetized rats.

Filippov IV, Williams WC, Krebs AA, Pugachev KS.

Brain Res. 2007 Feb 16;1133(1):78-86. Epub 2006 Dec 28.

PMID:
17196561
13.

New developments in flavivirus vaccines with special attention to yellow fever.

Pugachev KV, Guirakhoo F, Monath TP.

Curr Opin Infect Dis. 2005 Oct;18(5):387-94. Review.

PMID:
16148524
14.

Safety testing for neurovirulence of novel live, attenuated flavivirus vaccines: infant mice provide an accurate surrogate for the test in monkeys.

Monath TP, Myers GA, Beck RA, Knauber M, Scappaticci K, Pullano T, Archambault WT, Catalan J, Miller C, Zhang ZX, Shin S, Pugachev K, Draper K, Levenbook IS, Guirakhoo F.

Biologicals. 2005 Sep;33(3):131-44.

PMID:
15975826
15.

Recombination and flavivirus vaccines: a commentary.

Monath TP, Kanesa-Thasan N, Guirakhoo F, Pugachev K, Almond J, Lang J, Quentin-Millet MJ, Barrett AD, Brinton MA, Cetron MS, Barwick RS, Chambers TJ, Halstead SB, Roehrig JT, Kinney RM, Rico-Hesse R, Strauss JH.

Vaccine. 2005 Apr 27;23(23):2956-8. No abstract available.

PMID:
15811640
16.

Construction of yellow fever/St. Louis encephalitis chimeric virus and the use of chimeras as a diagnostic tool.

Pugachev KV, Guirakhoo F, Mitchell F, Ocran SW, Parsons M, Johnson BW, Kosoy OL, Lanciotti RS, Roehrig JT, Trent DW, Monath TP.

Am J Trop Med Hyg. 2004 Nov;71(5):639-45.

PMID:
15569798
17.

High fidelity of yellow fever virus RNA polymerase.

Pugachev KV, Guirakhoo F, Ocran SW, Mitchell F, Parsons M, Penal C, Girakhoo S, Pougatcheva SO, Arroyo J, Trent DW, Monath TP.

J Virol. 2004 Jan;78(2):1032-8.

18.

Clonal vaccinia virus grown in cell culture as a new smallpox vaccine.

Weltzin R, Liu J, Pugachev KV, Myers GA, Coughlin B, Blum PS, Nichols R, Johnson C, Cruz J, Kennedy JS, Ennis FA, Monath TP.

Nat Med. 2003 Sep;9(9):1125-30. Epub 2003 Aug 17.

PMID:
12925845
19.

Traditional and novel approaches to flavivirus vaccines.

Pugachev KV, Guirakhoo F, Trent DW, Monath TP.

Int J Parasitol. 2003 May;33(5-6):567-82. Review.

PMID:
12782056
20.

Heterogeneous nature of the genome of the ARILVAX yellow fever 17D vaccine revealed by consensus sequencing.

Pugachev KV, Ocran SW, Guirakhoo F, Furby D, Monath TP.

Vaccine. 2002 Jan 15;20(7-8):996-9.

PMID:
11803058

Supplemental Content

Loading ...
Support Center